Innoviva Inc (INVA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.35B
Last updated: Nov 17, 2026 at 11:06 AM ET
Innoviva Inc (INVA) Earnings: Report Dates and Results
Innoviva (INVA) is expected to report earnings on Feb 23, 2027. In the quarter ended Sep 30, 2026, Innoviva reported EPS of $0.50, above the $0.49 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
INVA has an expected report date of Feb 23, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 76.8% below the $1.94 reported for the quarter ended Dec 31, 2025.
Earnings History
Of the 39 quarters below that had an estimate, INVA beat 18, missed 20 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $106.12M, down 1.6% from $107.80M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.50 | $0.49 | -$0.36 - $0.57 | +2.04% | Beat | -53.7% | 5 | 1 up, 0 down | Nov 4, 2026 | $106.12M |
| Jun 30, 2026 | $0.59 | $0.56 | N/A | +5.36% | Beat | -23.4% | 1 | 1 up, 1 down | Aug 5, 2026 | $119.59M |
| Mar 31, 2026 | $0.47 | $0.43 | $0.43 - $0.43 | +9.30% | Beat | N/A | 1 | 1 up, 0 down | May 6, 2026 | $97.99M |
| Dec 31, 2025 | $1.94 | $0.57 | N/A | +238.68% | Beat | +647.7% | 2 | 0 up, 2 down | Feb 25, 2026 | $114.61M |
| Sep 30, 2025 | $1.08 | $0.46 | N/A | +134.78% | Beat | +800.0% | 2 | 0 up, 0 down | Nov 5, 2025 | $107.80M |
| Jun 30, 2025 | $0.77 | $0.50 | N/A | +54.00% | Beat | N/A | N/A | 0 up, 0 down | Aug 6, 2025 | $100.28M |
| Mar 31, 2025 | -$0.74 | $0.33 | N/A | -325.12% | Miss | -261.5% | N/A | 0 up, 0 down | May 7, 2025 | $88.63M |
| Dec 31, 2024 | $0.26 | $0.41 | $0.41 - $0.41 | -36.59% | Miss | -65.8% | 1 | 2 up, 0 down | Feb 26, 2025 | $91.81M |
| Sep 30, 2024 | $0.12 | $0.27 | $0.22 - $0.31 | -55.56% | Miss | -33.3% | 2 | 0 up, 0 down | Nov 6, 2024 | $89.51M |
| Jun 30, 2024 | -$0.55 | $0.24 | $0.22 - $0.25 | -329.17% | Miss | -2850.0% | 2 | 0 up, 0 down | Jul 31, 2024 | $99.90M |
| Mar 31, 2024 | $0.46 | $0.17 | $0.17 - $0.17 | +170.59% | Beat | +9.5% | 1 | 0 up, 0 down | May 8, 2024 | $77.50M |
| Dec 31, 2023 | $0.76 | $0.23 | $0.23 - $0.23 | +230.43% | Beat | N/A | 1 | 0 up, 0 down | Feb 29, 2024 | $85.84M |
| Sep 30, 2023 | $0.18 | $0.27 | $0.27 - $0.27 | -33.33% | Miss | -66.7% | 1 | 0 up, 0 down | Nov 1, 2023 | $67.26M |
| Jun 30, 2023 | $0.02 | $0.26 | N/A | -92.31% | Miss | -96.8% | 1 | 0 up, 0 down | Aug 2, 2023 | $80.99M |
| Mar 31, 2023 | $0.42 | $0.23 | $0.23 - $0.23 | +82.61% | Beat | -4.5% | 1 | 0 up, 0 down | May 9, 2023 | $76.37M |
| Dec 31, 2022 | -$0.98 | $0.23 | $0.04 - $0.41 | -526.09% | Miss | -800.0% | 2 | 0 up, 0 down | Feb 28, 2023 | $65.80M |
| Sep 30, 2022 | $0.54 | $2.24 | $0.31 - $3.67 | -75.89% | Miss | -40.0% | 3 | 1 up, 0 down | Nov 9, 2022 | $67.26M |
| Jun 30, 2022 | $0.62 | $0.44 | N/A | +40.91% | Beat | -31.1% | 1 | 0 up, 1 down | Jul 27, 2022 | $108.22M |
| Mar 31, 2022 | $0.44 | $0.48 | $0.40 - $0.48 | -8.33% | Miss | -47.6% | 2 | 0 up, 0 down | Apr 27, 2022 | $90.06M |
| Dec 31, 2021 | $0.14 | $0.41 | $0.41 - $0.41 | -65.85% | Miss | -74.5% | 1 | 0 up, 0 down | Feb 9, 2022 | $107.68M |
| Sep 30, 2021 | $0.90 | $0.43 | N/A | +109.30% | Beat | +95.7% | N/A | N/A | Oct 27, 2021 | $97.86M |
| Jun 30, 2021 | $0.90 | $0.29 | $0.29 - $0.29 | +210.34% | Beat | +172.7% | 1 | N/A | Jul 28, 2021 | $100.81M |
| Mar 31, 2021 | $0.84 | -$0.01 | N/A | N/A | N/A | +100.0% | N/A | N/A | Apr 28, 2021 | $85.52M |
| Dec 31, 2020 | $0.55 | $0.40 | $0.40 - $0.40 | +37.50% | Beat | +31.0% | 1 | N/A | Feb 3, 2021 | $90.48M |
| Sep 30, 2020 | $0.46 | $0.42 | $0.42 - $0.42 | +9.52% | Beat | +27.8% | 1 | N/A | Oct 28, 2020 | $88.69M |
| Jun 30, 2020 | $0.33 | $0.32 | $0.32 - $0.32 | +3.13% | Beat | -2.9% | 1 | N/A | Jul 29, 2020 | $78.95M |
| Mar 31, 2020 | $0.42 | $0.36 | $0.29 - $0.43 | +16.67% | Beat | +35.5% | 2 | N/A | Apr 29, 2020 | $78.68M |
| Dec 31, 2019 | $0.42 | $0.50 | $0.39 - $0.60 | -16.00% | Miss | -30.0% | 2 | N/A | Feb 5, 2020 | $75.97M |
| Sep 30, 2019 | $0.36 | $0.37 | $0.33 - $0.40 | -2.70% | Miss | -18.2% | 2 | N/A | Oct 30, 2019 | $65.75M |
| Jun 30, 2019 | $0.34 | $0.42 | $0.42 - $0.43 | -19.05% | Miss | -30.6% | 2 | N/A | Jul 24, 2019 | $64.11M |
| Mar 31, 2019 | $0.31 | $0.36 | $0.34 - $0.38 | -13.89% | Miss | +14.8% | 2 | N/A | May 1, 2019 | $55.18M |
| Dec 31, 2018 | $0.60 | $0.65 | $0.65 - $0.65 | -7.69% | Miss | +25.0% | 1 | N/A | Feb 6, 2019 | $79.86M |
| Sep 30, 2018 | $0.44 | $0.42 | N/A | +4.76% | Beat | +57.1% | 1 | N/A | Oct 31, 2018 | $61.68M |
| Jun 30, 2018 | $0.49 | $0.55 | $0.55 - $0.55 | -10.91% | Miss | +63.3% | 1 | N/A | Jul 26, 2018 | $67.09M |
| Mar 31, 2018 | $0.27 | $0.53 | $0.50 - $0.59 | -49.06% | Miss | +80.0% | 2 | N/A | Apr 26, 2018 | $52.38M |
| Dec 31, 2017 | $0.48 | $0.49 | N/A | -2.04% | Miss | +118.2% | 3 | N/A | Feb 8, 2018 | $69.52M |
| Sep 30, 2017 | $0.28 | $0.33 | $0.28 - $0.36 | -15.15% | Miss | +115.4% | 3 | N/A | Oct 25, 2017 | $48.64M |
| Jun 30, 2017 | $0.30 | $0.29 | $0.23 - $0.30 | +3.45% | Beat | +130.8% | 3 | N/A | Jul 26, 2017 | $58.56M |
| Mar 31, 2017 | $0.15 | $0.28 | N/A | -46.43% | Miss | +275.0% | N/A | N/A | Apr 27, 2017 | $40.49M |
| Dec 31, 2016 | $0.22 | $0.22 | N/A | 0.00% | In line | +450.0% | N/A | N/A | Feb 9, 2017 | $43.61M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $3.05, up 952.1% from the year before. It was $0.52 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $3.05 | +952.1% |
| Dec 31, 2024 | $0.29 | -79.0% |
| Dec 31, 2023 | $1.38 | +122.6% |
| Dec 31, 2022 | $0.62 | -77.7% |
| Dec 31, 2021 | $2.78 | +58.0% |
| Dec 31, 2020 | $1.76 | +23.1% |
| Dec 31, 2019 | $1.43 | -20.6% |
| Dec 31, 2018 | $1.80 | +48.8% |
| Dec 31, 2017 | $1.21 | +132.7% |
| Dec 31, 2016 | $0.52 | N/A |
Frequently Asked Questions About INVA
When is Innoviva's next earnings date?
Innoviva's next earnings report is expected for Feb 23, 2027.
Did INVA beat earnings estimates last quarter?
Yes. Innoviva reported EPS of $0.50 for the quarter ended Sep 30, 2026, above the $0.49 estimate, a 2.04% surprise.
What EPS do analysts expect from INVA next quarter?
The consensus EPS estimate for Innoviva for the quarter ending Dec 31, 2026 is $0.45 from 7 analysts, with estimates from $0.34 to $0.56.
How often does INVA beat earnings estimates?
Innoviva beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +10.31%.
INVA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors